You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中生製藥(01177.HK)料中績多賺逾5倍 股價曾反彈逾9%
中生製藥(01177.HK)盈喜料中績多賺逾5倍,該股今早扭六連跌重越10天及20天線,最多漲9.1%高見7.05元(暫受制50天線7.18),現報6.75元,回升4.5%,成交增至8,393萬股。 中生製藥發盈喜指,受益於主營業務表現令人滿意,期內新產品、高毛利率產品銷售佔比上升,收入及毛利率按年明顯提升以及聯營公司財務表現強勁,預計截至6月止六個月中期純利將較去年同期12.41億人民幣增長逾5倍。 美國7月新屋動工量環比三個月來首降7%遠遜預期,聯儲局上次會議紀錄顯示,多數委員認為局方適合年內開始減少買債。美股三大指數昨晚全面低收續跌0.9%-1.1%,道指挫382點或1.1%收34,960。亞太區股市除新西蘭股逆市續升1.4%外,全部受壓,港股跌幅最大,恆指在新經濟股阿里巴巴(09988.HK)/美團(03690.HK),以及中績少賺近18%遭大行削價的恆安(00144.HK)跌幅擴至逾3%-4%等藍籌普遍向下拖累,跌幅擴至363點或1.4%報25,503,成交額443億元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account